Professional Acitivities

 Abuse-Deterrent Pharmaceutical Dosage Forms
  • Over 3 years of experience with abuse-deterrent pharmaceutical dosage forms
  • Supervising three PhD students developing novel abuse-deterrent pharmaceutical dosage forms
  • Supervising 12 PharmD and international pharmacy students on different aspects of drugs of abuse, methods of abuse, and deterrent technologies
  • Well-familiar with all commercial abuse-deterrent technologies
  • Well-familiar with current know-how on abuse-deterrent systems and technologies
  • Provided expert opinion regarding abuse-deterrent technologies
  • Primary inventor of five inventions

Drug Delivery Systems and Technologies
  • Over 5 years of intensive and extensive experience in developing gastro-retentive swellable polymers for drug delivery application
  • Co-authored a book chapter titled “Drug Delivery Systems and Targeting” in the 6th edition of
  • Martin’s Physical Pharmacy and Pharmaceutical Sciences
  • Co-authored a book chapter titled “Commercial Oral Controlled Release Solid Dosage Forms”
  • Co-authored a book chapter titled “Oral Controlled Delivery Mechanisms and Technologies”
  • Co-authored a book chapter titled “Mucoadhesive Drug Delivery Systems”
  • Co-authored a book chapter titled “Polymers in Drug Delivery”
  • Successfully completed a 3.5 CEUs course on “Advanced Drug Delivery” at Massachusetts Institute of Technology
  • Familiar with preparation and application of liposome, polymerosomes, and modified liposome for variety of drug delivery applications
  • Familiar with matrix systems, reservoir systems, mucoadhesion and bioadhesion, solvent-activated controlled release systems, bioerodible systems, topical and transdermal systems, oral delivery, mucosal delivery, microparticulate drug delivery, liposome, implants, aerosols, inserts, protein stability, controlled release fabrication, controlled release applications, tablets, capsules, powders, granules, semisolids (creams, ointments, pastes, lotions), immediate/extended/sustained/delayed/targeted drug release, and more
  • Serving on the editorial board of the “Advanced Pharmaceutical Bulletin”
Gastro-Retentive Drug Delivery Systems
  • Hands-on experience in developing gastro-retentive platforms based on floating, mucoadhesion, expansion and swelling mechanisms
  • Over 5 years intensive and extensive experience in developing gastric retention platforms based on the swelling concept
  • Over 3 years intensive experience in developing gastric retention platforms based on the expansion concept
  • Designed superporous hydrogels for delivery of semi-solid formulations
  • Designed superporous hydrogels for delivery of solid formulations
  • Co-authored a book chapter titled “Oral Targeted Drug Delivery Systems: Gastric Retention Devices”
  • Published a few peer-reviewed manuscripts
  • Presented many posters at major conferences
Proof of Concept Studies
  • Developed and tested products for the proof of concepts studies for two major projects of gastric retention and diet platforms
  • Contributed in manufacturing supplies and implementing in-vivo animal, stability, safety, toxicity, and human trial studies

 

 

Hamid Omidian

Associate Professor

 

  • : 954-262-1334

  • DEPARTMENTDepartment of Pharmaceutical Sciences
    Nova Southeastern University
  • COUNTRY USA